Cann American(OTC) CNNA

Cann American Corp. is an early-stage enterprise focused on developing specialized Cannabis sativa varieties for animal consumption. The company targets markets within various European Union countries and aims to innovate within the healthcare sector.

Products and Services

• Specialized Cannabis sativa varieties for animal consumption
• Research and development in cannabis applications
• Market expansion strategies in the European Union

Growth Outlook

• Established in 2004, Cann American Corp. has a long history in the cannabis sector
• Focus on European markets presents significant growth opportunities
• Innovative product development aligns with increasing demand for cannabis-based animal products

Financial Highlights

• Recent quarterly revenue of $3, consistent over two quarters
• Trailing twelve months (TTM) net income margin shows potential for improvement
• Cash and short-term investments totaled $59.872 as of August 2020

Cann American Corp. operates in the Drug Manufacturers - Specialty & Generic industry, with a strategic focus on developing cannabis products tailored for animal consumption. The company has maintained a steady revenue stream of $3 over the last two quarters, indicating stability in its operations. The TTM financial data suggests that while there are challenges, there is potential for improvement in net income margins. The company's cash and short-term investments position it to explore further growth opportunities, particularly in the expanding European market. With a commitment to innovation and a clear focus on specialized products, Cann American Corp. is poised to capitalize on the growing demand for cannabis-based solutions in the animal health sector.